Ad is loading...
ABPAX
Price
$12.39
Change
-$0.12 (-0.96%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

ABPAX vs RAMHX

Header iconABPAX vs RAMHX Comparison
Open Charts ABPAX vs RAMHXBanner chart's image
AB Sustainable Thematic Bal Port A
Price$12.39
Change-$0.12 (-0.96%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
ABPAX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABPAX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABPAX is a Buy and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. ABPAX (95.5M). RAMHX pays higher dividends than ABPAX: RAMHX (1.84) vs ABPAX (0.85). ABPAX was incepted earlier than RAMHX: ABPAX (21 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. ABPAX (46.00). RAMHX has a lower initial minimum investment than ABPAX: RAMHX (250) vs ABPAX (2500). RAMHX annual gain was more profitable for investors over the last year : 20.31 vs. ABPAX (13.75). RAMHX return over 5 years is better than : 32.43 vs. ABPAX (6.09).
ABPAXRAMHXABPAX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years10 years-
Gain YTD6.90313.58251%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets95.5M236B0%
Annual Yield % from dividends0.851.8446%
Returns for 1 year13.7520.3168%
Returns for 3 years-7.269.39-77%
Returns for 5 years6.0932.4319%
Returns for 10 years19.0146.7441%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings